Literature DB >> 11889005

Modulating cardiac hypertrophy by manipulating myocardial lipid metabolism?

Norbert Frey, Eric N Olson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889005

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Nutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and ω-3 Polyunsaturated Fatty Acids.

Authors:  Hongyu Xue; Wenhua Ren; Melanie Denkinger; Ewald Schlotzer; Paul E Wischmeyer
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-04-17       Impact factor: 4.016

2.  Myocardial metabolic regulation through peroxisome proliferator-activated receptor alpha after myocardial infarction.

Authors:  Katsuhiko Masamura; Nobuyoshi Tanaka; Masahiro Yoshida; Masayuki Kato; Yasuyuki Kawai; Koji Oida; Isamu Miyamori
Journal:  Exp Clin Cardiol       Date:  2003

Review 3.  Thiazolidinediones: effects on insulin resistance and the cardiovascular system.

Authors:  C E Quinn; P K Hamilton; C J Lockhart; G E McVeigh
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

4.  Therapeutic Implications of PPARgamma in Cardiovascular Diseases.

Authors:  Hiroshi Hasegawa; Hiroyuki Takano; Issei Komuro
Journal:  PPAR Res       Date:  2010-08-12       Impact factor: 4.964

5.  The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart.

Authors:  Laura Mele; Lauren J Maskell; Daniel J Stuckey; James E Clark; Richard J Heads; Vishwanie S Budhram-Mahadeo
Journal:  Cell Death Dis       Date:  2019-08-14       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.